NCT07445698

Brief Summary

During laparoscopic procedures, certain physiological changes occur due to the creation of pneumoperitoneum. One such change is the reduction in portal venous blood flow, which can lead to decreased liver perfusion and acute liver cell injury. Additionally, due to an increased alveolar-arterial oxygen pressure gradient, postoperative atelectasis may occur, leading to hypoxia. In other words, the increased intra-abdominal pressure during laparoscopic surgery-along with the effects of patient positioning and mechanical ventilation used during anesthesia-can worsen low blood oxygen levels, especially in patients with already reduced lung compliance and higher metabolic demands. This makes close monitoring of oxygenation crucial. The Oxygen Reserve Index (ORI) is a relatively new tool that can help monitor both high oxygen levels (hyperoxemia) and drops in oxygen (desaturation) before they become clinically apparent. Studies have shown that ORI values range from 0 to 1, with an ORI of 0 typically corresponding to a PaO₂ level between 80-125 mmHg. A downward trend in ORI can act as an early warning sign of hypoxemia, giving clinicians a chance to act before it's too late. Many studies have highlighted the potential harms of using high oxygen concentrations during surgery. For example, while most hospitals still give patients 100% oxygen before anesthesia (a process called preoxygenation), recent evidence suggests this might increase the risk of atelectasis. Therefore, using 80% or less oxygen is now being recommended in many settings. High oxygen levels have also been linked to increased oxidative stress in the body. In this study, we aim to investigate whether monitoring ORI during extubation can help us detect and prevent both hyperoxemia and hypoxemia-situations that standard pulse oximetry often misses. We plan to compare two groups of patients: one receiving conventional 100% oxygen during extubation, and another receiving 80% oxygen. By monitoring ORI values in both groups, we hope to better understand how different oxygen levels affect patient safety and outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 7, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 19, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2026

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 3, 2026

Completed
Last Updated

March 3, 2026

Status Verified

February 1, 2026

Enrollment Period

12 months

First QC Date

September 19, 2025

Last Update Submit

February 25, 2026

Conditions

Keywords

ORİFİO2laparoscopic colorectal surgeryextubationpao2

Outcome Measures

Primary Outcomes (1)

  • Oxygen Reserve Index (ORI ) at 5 minutes post-extubation

    Oxygen Reserve Index (ORI) will be continuously monitored using a Masimo Radical-7 pulse co-oximeter from the time of extubation until 60 minutes post-extubation. The ORI value recorded at the 5th minute after tracheal extubation will be used for primary outcome analysis.

    ORI will be recorded at 5 minutes post-extubation using a Masimo Radical-7 pulse co-oximeter to assess peri-extubation oxygen reserve.

Secondary Outcomes (6)

  • Peripheral Oxygen Saturation (SpO₂, %) trends during and after extubation

    Continuous monitoring during and up to 60 minutes after tracheal extubation

  • Arterial oxygen partial pressure (PaO₂, mmHg) at 5 minutes post-extubation

    5 minutes after tracheal extubation

  • Oxygen Reserve Index (ORI) at 60 minutes post-extubation

    60 minutes after tracheal extubation

  • Arterial oxygen partial pressure (PaO₂, mmHg) at 60 minutes post-extubation

    60 minutes after tracheal extubation

  • Heart rate during the first postoperative hour

    From extubation until 60 minutes post-extubation

  • +1 more secondary outcomes

Study Arms (2)

Group 1 - 100% Oxygen Group

Patients in this group will receive 100% oxygen during tracheal extubation in laparoscopic colorectal surgery. Oxygenation will be monitored continuously using the Oxygen Reserve Index (ORI) and arterial PaO₂. The intervention is non-invasive and administered via standard anesthesia breathing systems.

Behavioral: Oxygen Administration During Extubation

Group 2 - 80% Oxygen Group

Patients in this group will receive 80% oxygen during tracheal extubation in laparoscopic colorectal surgery. Oxygenation will be monitored continuously using the Oxygen Reserve Index (ORI) and arterial PaO₂. The intervention is non-invasive and administered via standard anesthesia breathing systems.

Behavioral: Oxygen Administration During Extubation

Interventions

This intervention involves the administration of oxygen during tracheal extubation in patients undergoing laparoscopic surgery. Two different oxygen concentrations are compared: the control group receives 100% oxygen, while the study group receives 80% oxygen during the extubation phase. All patients are monitored using the Oxygen Reserve Index (ORI) to assess oxygenation status continuously. The goal is to evaluate the effect of oxygen concentration on peri-extubation hyperoxia and hypoxia, as detected by ORI values. The intervention is non-invasive and administered via standard anesthesia breathing systems.

Group 1 - 100% Oxygen GroupGroup 2 - 80% Oxygen Group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Sixty volunteer patients, aged between 18 and 75, with a Body Mass Index (BMI) below 35 and ASA class I and II, who are scheduled to undergo laparoscopic hysterectomy, will be included.

You may qualify if:

  • Age: 18-75
  • ASA: I-II
  • Scheduled for elective laparoscopic surgery
  • BMI \<35

You may not qualify if:

  • Patients undergoing emergency surgery due to trauma
  • Patients with ASA physical status classification III or IV
  • Patients requiring intensive care unit admission
  • Patients with active, clinically symptomatic anemia
  • Patients with heart failure
  • Patients with known allergy to the sensor material to be used
  • Patients with difficult mask ventilation or difficult intubation
  • Patients with a platelet count below 30,000/mm³
  • Patients with a history of gastrointestinal bleeding within the past 6 months
  • Patients with a history of bleeding diathesis or increased risk of intracerebral hemorrhage
  • Patients with oliguria and/or those who required dialysis or underwent dialysis within one month prior to surgery
  • Patients with a known hypersensitivity reaction to any anesthetic or analgesic drug used in the study
  • Patients who do not wish to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kartal Dr. Lütfi Kırdar Eğitim ve Araştırma hastanesi

Istanbul, Kartal, 34865, Turkey (Türkiye)

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
medical doctor

Study Record Dates

First Submitted

September 19, 2025

First Posted

March 3, 2026

Study Start

January 7, 2025

Primary Completion

December 30, 2025

Study Completion

February 10, 2026

Last Updated

March 3, 2026

Record last verified: 2026-02

Locations